Related Concepts
Related Feeds
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Related Papers
Mediterranean Journal of Hematology and Infectious Diseases
Pau Montesinos, Miguel A Sanz
Mediterranean Journal of Hematology and Infectious Diseases
E M Rego, G C De Santis
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Yan-Hui LiuChang-Geng Ruan
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Li JiaoTi Shen
Best Practice & Research. Clinical Haematology
Richard S Larson, Martin S Tallman